Shares of Liberty Health Sciences Inc (OTCMKTS:LHSIF) have been on the rebound so far this week. We suggested as much in our last piece on the stock, noting that sentiment had deteriorated too far given the footprint being constructed by the company. As a case in point, Liberty just announced that it has opened its first South Florida dispensary today in the heart of Miami on Bird Road. The new dispensary provides customers in Miami-Dade County, the most populous county in Florida, access to premium quality medical marijuana products and educational services.
According to the release, “Bird Road is one of the oldest and busiest state roads in Miami, with traffic exceeding 70,000 vehicles per day. It is a primary artery that feeds the main suburbs in Miami such as Coral Gables, West Miami, South Miami, Westchester, and Kendall. In addition to the Miami location, Liberty plans to open 3 more dispensaries this month with more to come in 2019, all subject to the receipt of Florida Department of Health approvals.”
Liberty Health Sciences Inc (OTCMKTS:LHSIF) frames itself as a company that engages in the production and distribution of medical cannabis primarily in the State of Florida.
It has a strategic partnership with Veterans Cannabis Project to support various research projects focused on the treatment of service related trauma with cannabis derived products; and partnership with AdaViv Inc. to enhance production of cannabis.
The company is headquartered in Toronto, Canada.
Liberty Health Sciences was established to own and operate medical marijuana licenses in the United States. To date, the company owns one of 14 licenses issued in the state of Florida as well as 50.1% interest in a provisional processing license and a provisional dispensary license, both in Ohio. Liberty has also made an investment in a provisional medical license in the Commonwealth of Massachusetts.
According to company materials, “Liberty is the cannabis provider committed to providing a trusted, high-quality cannabis experience based on our genuine care for all cannabis users and a focus on operational excellence from seed to sale and beyond. Liberty’s measured approach to expansion opportunities maximizes returns to shareholders, while keeping consumers’ well-being at the forefront of what we do.”
Find out when $LHSIF reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, LHSIF just announced that it has opened its first south Florida dispensary today in the heart of Miami on Bird Road. The new dispensary provides customers in Miami-Dade County, the most populous county in Florida, access to premium quality medical marijuana products and educational services.
The chart shows 14% added to share values of the listing over the past week of action. Furthermore, the stock has benefitted from a jump in recent trading volume to the tune of topping 170% above the average volume levels in play in this stock over the longer term.
“Liberty remains committed to ensuring that its premium quality medical marijuana products and educational services are accessible to the more than 2.7 million people who call South Florida home,” said George Scorsis, CEO of Liberty Health Sciences. “When people come to our dispensaries, they know they will find the highest quality medicinal cannabis. They also trust that they are going to have access to the best brands in any category, including PAX and Mary’s Medicinals products.
Now commanding a market cap of $272.85M, LHSIF has a significant war chest ($26.1M) of cash on the books, which compares with about $4M in total current liabilities. LHSIF is pulling in trailing 12-month revenues of $3.9M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 4619.5%. This may be a very interesting story and we will look forward to updating it again soon. Sign-up for continuing coverage on shares of $LHSIF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $LHSIF, either long or short, and we have not been compensated for this article.